Global Report: A Hope and a Payer - Pharmaceutical Executive


Global Report: A Hope and a Payer
If current trends continue, the United Kingdom will spend 12.7 percent of its GDP on healthcare by 2050. Maybe that means it's time to reform the National Health Service's notoriously complex drug payment scheme.

Pharmaceutical Executive

Sarah Houlton, PhD, is Pharmaceutical Executive's global correspondent. She can be reached at


blog comments powered by Disqus

Source: Pharmaceutical Executive,
Click here